Clinical research advances in the treatment of alopecia areata with systemic small-molecule drugs and biologics
10.35541/cjd.20240247
- VernacularTitle:系统小分子药物和生物制剂治疗斑秃的临床研究进展
- Author:
Xiangqian LI
1
;
Jianzhong ZHANG
1
;
Cheng ZHOU
1
Author Information
1. 北京大学人民医院皮肤科，北京 100044
- Publication Type:Journal Article
- Keywords:
Alopecia areata;
Janus kinase inhibitors;
Molecular targeted therapy;
Biologics
- From:
Chinese Journal of Dermatology
2025;58(7):646-649
- CountryChina
- Language:Chinese
-
Abstract:
Alopecia areata (AA) is an autoimmune-mediated, hair follicle-targeting, inflammatory, non-scarring hair loss. The treatment of severe AA has long been a focus and challenge. Currently, novel therapeutic agents, such as Janus kinase (JAK) inhibitors, have been increasingly employed in the treatment of severe AA. This review provides an overview of new small-molecule targeted drugs and biologics for AA.
